======= TNFRSF13B =======
== Gene Information ==
* **Official Symbol**: TNFRSF13B
* **Official Name**: TNF receptor superfamily member 13B
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=23495|23495]]
* **UniProt**: [[https://www.uniprot.org/uniprot/O14836|O14836]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=TNFRSF13B&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20TNFRSF13B|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/604907|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: The protein encoded by this gene is a lymphocyte-specific member of the tumor necrosis factor (TNF) receptor superfamily. It interacts with calcium-modulator and cyclophilin ligand (CAML). The protein induces activation of the transcription factors NFAT, AP1, and NF-kappa-B and plays a crucial role in humoral immunity by interacting with a TNF ligand. This gene is located within the Smith-Magenis syndrome region on chromosome 17. [provided by RefSeq, Jul 2008].
* **UniProt Summary**: Receptor for TNFSF13/APRIL and TNFSF13B/TALL1/BAFF/BLYS that binds both ligands with similar high affinity. Mediates calcineurin-dependent activation of NF-AT, as well as activation of NF-kappa-B and AP-1. Involved in the stimulation of B- and T- cell function and the regulation of humoral immunity. {ECO:0000269|PubMed:10956646, ECO:0000269|PubMed:10973284}.
|TACI-CRD2|
|negative regulation of B cell proliferation|
|B cell homeostasis|
|negative regulation of B cell activation|
|lymphocyte homeostasis|
|regulation of B cell proliferation|
|leukocyte homeostasis|
|negative regulation of lymphocyte proliferation|
|negative regulation of mononuclear cell proliferation|
|negative regulation of leukocyte proliferation|
|hematopoietic progenitor cell differentiation|
|tumor necrosis factor-mediated signaling pathway|
|negative regulation of lymphocyte activation|
|negative regulation of leukocyte activation|
|negative regulation of cell activation|
|homeostasis of number of cells|
|signaling receptor activity|
|regulation of B cell activation|
|regulation of lymphocyte proliferation|
|regulation of mononuclear cell proliferation|
|regulation of leukocyte proliferation|
|cellular response to tumor necrosis factor|
|response to tumor necrosis factor|
|negative regulation of immune system process|
|regulation of lymphocyte activation|
|hemopoiesis|
|regulation of leukocyte activation|
|hematopoietic or lymphoid organ development|
|adaptive immune response|
|regulation of cell activation|
|immune system development|
|cytokine-mediated signaling pathway|
|negative regulation of cell population proliferation|
|cellular response to cytokine stimulus|
|response to cytokine|
|integral component of plasma membrane|
|regulation of cell population proliferation|
|homeostatic process|
|regulation of immune system process|
|immune response|
\\
=== CRISPR Data ===
No hits were found.
No correlation found to any other genes in chemogenomics.
Global Fraction of Cell Lines Where Essential: 0/739
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|0/1|
|909776.0|0/1|
|bile duct|0/28|
|blood|0/28|
|bone|0/26|
|breast|0/33|
|central nervous system|0/56|
|cervix|0/4|
|colorectal|0/17|
|esophagus|0/13|
|fibroblast|0/1|
|gastric|0/16|
|kidney|0/21|
|liver|0/20|
|lung|0/75|
|lymphocyte|0/16|
|ovary|0/26|
|pancreas|0/24|
|peripheral nervous system|0/16|
|plasma cell|0/15|
|prostate|0/1|
|skin|0/24|
|soft tissue|0/9|
|thyroid|0/2|
|upper aerodigestive|0/22|
|urinary tract|0/29|
|uterus|0/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 11542
* **Expression level (log2 read counts)**: 2.28
{{:chemogenomics:nalm6 dist.png?nolink |}}